Delivery Order SPE2DB22D1202-SPE2DB25FUTT8
Award Date
2/26/25
Potential Completion Date
2/27/25
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,967.80, is for the delivery of 4566747214 - ROCURONIUM 100 MG/10 ML VIAL 10ML. It is a firm fixed-price delivery order contract with a completion date of December 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of ROCURONIUM 100 MG/10 ML VIAL 10ML to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The $1,128.03 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 9, 2024, with a final completion date of August 12, 2024. This contract is not associated with a set-aside program. Amerisourcebergen holds several indefinite delivery contracts (IDCs) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,558,029,625 units of the drug Rocuronium 50 mg/5 ml vial with a 5 ml volume. The $1,097.76 firm fixed price delivery order has an ultimate completion date of August 9, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,550,071 units of Rocuronium 100 mg/10 ml vials. The $1,231.45 fixed-price contract has an ultimate completion date of August 23, 2024. The award is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office division, has been a significant provider of critical medical commodities to various federal...
This federal contract award, with an ID of SPE2DX15D2223|SPE2DX24F4LAQ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued at $1,068.66, is for the delivery of 4565910342 - ROCURONIUM 100 MG/10 ML VIAL 10ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of September 24, 2024. The contract was awarded on September 23, 2024...
The federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide 4,565,704,171 units of the drug Rocuronium 50 mg/5 ml vial. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order valued at $1,813.95. The contract has no set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of Rocuronium Bromide, a muscle relaxant medication, with a total ceiling value of $2,246.72 and a performance period through December 26, 2023. Amerisourcebergen Drug Corp has received numerous similar federal contract awards from DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,162.25 firm fixed-price delivery order is for 4563554227 - Ropivacaine 0.2% 400 mg/200 ml, a pharmaceutical product used for pain management. The contract has an ultimate completion date of February 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,154.86, is for the delivery of various pharmaceutical products and medical supplies to support federal healthcare programs, particularly military and veterans' healthcare systems. The contract is a firm fixed price delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a firm fixed price Delivery Order contract worth $1,182.71 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This delivery order is for the supply of pharmaceutical products, including a 0.25% 10ML medication, to support military treatment programs and facilities. The contract has a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA,...